RU2473327C2 - Композиция для борьбы с эпистаксисом - Google Patents
Композиция для борьбы с эпистаксисом Download PDFInfo
- Publication number
- RU2473327C2 RU2473327C2 RU2009134086/15A RU2009134086A RU2473327C2 RU 2473327 C2 RU2473327 C2 RU 2473327C2 RU 2009134086/15 A RU2009134086/15 A RU 2009134086/15A RU 2009134086 A RU2009134086 A RU 2009134086A RU 2473327 C2 RU2473327 C2 RU 2473327C2
- Authority
- RU
- Russia
- Prior art keywords
- gel
- concentration
- glycine
- calcium ions
- epistaxis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0703377.2 | 2007-02-21 | ||
| GB0703377A GB2447012B (en) | 2007-02-21 | 2007-02-21 | Composition for combating epistaxis |
| PCT/GB2008/000608 WO2008102150A2 (en) | 2007-02-21 | 2008-02-21 | Composition for combating epistaxis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2009134086A RU2009134086A (ru) | 2011-03-27 |
| RU2473327C2 true RU2473327C2 (ru) | 2013-01-27 |
Family
ID=37909023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009134086/15A RU2473327C2 (ru) | 2007-02-21 | 2008-02-21 | Композиция для борьбы с эпистаксисом |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9138406B2 (enExample) |
| EP (1) | EP2117502B1 (enExample) |
| JP (1) | JP2010519285A (enExample) |
| KR (1) | KR20090130001A (enExample) |
| CN (1) | CN101677940B (enExample) |
| AU (1) | AU2008217608B2 (enExample) |
| BR (1) | BRPI0807732B8 (enExample) |
| CA (1) | CA2678706C (enExample) |
| DK (1) | DK2117502T3 (enExample) |
| ES (1) | ES2606947T3 (enExample) |
| GB (1) | GB2447012B (enExample) |
| HR (1) | HRP20161626T1 (enExample) |
| HU (1) | HUE031199T2 (enExample) |
| IL (1) | IL200277A0 (enExample) |
| PL (1) | PL2117502T3 (enExample) |
| PT (1) | PT2117502T (enExample) |
| RU (1) | RU2473327C2 (enExample) |
| WO (1) | WO2008102150A2 (enExample) |
| ZA (1) | ZA200905519B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2447012B (en) | 2007-02-21 | 2011-03-16 | Pharmacure Health Care Ab | Composition for combating epistaxis |
| USD993736S1 (en) | 2023-05-17 | 2023-08-01 | Line Work Bucket Products, LLC | Auger and socket holder |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2156612C1 (ru) * | 2000-03-13 | 2000-09-27 | Волков Александр Григорьевич | Способ остановки носового кровотечения |
| WO2003000155A2 (en) * | 2001-06-22 | 2003-01-03 | Millard Marsden Mershon | Compositions and methods for reducing blood and fluid loss from open wounds |
| US20030060486A1 (en) * | 2001-02-15 | 2003-03-27 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| WO2006005340A1 (en) * | 2004-07-09 | 2006-01-19 | Ferrosan A/S | Haemostatic composition comprising hyaluronic acid |
| RU2290937C1 (ru) * | 2005-10-03 | 2007-01-10 | Владислав Владимирович Петров | Способ остановки носового кровотечения |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4363319A (en) * | 1980-06-30 | 1982-12-14 | Applied Medical Devices, Inc. | Ready-to-use bandage incorporating a coagulant composition and method of preparing same |
| JPS63174924A (ja) * | 1987-01-14 | 1988-07-19 | Toko Yakuhin Kogyo Kk | 軟膏基剤および軟膏剤 |
| CA2121028A1 (en) * | 1991-10-11 | 1993-04-15 | Ulla K. E. Hedner | Hemostatic composition for local hemostasis |
| CN1091315A (zh) * | 1992-10-08 | 1994-08-31 | E·R·斯奎布父子公司 | 血纤维蛋白封闭剂组合物及其使用方法 |
| US5928611A (en) * | 1995-06-07 | 1999-07-27 | Closure Medical Corporation | Impregnated applicator tip |
| US6365131B1 (en) * | 1997-10-31 | 2002-04-02 | J. B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic |
| US6818018B1 (en) * | 1998-08-14 | 2004-11-16 | Incept Llc | In situ polymerizable hydrogels |
| CA2377088A1 (en) * | 1999-06-30 | 2001-01-04 | Scott Cordray | Nasal spray having dead sea salts |
| US20050232868A1 (en) * | 1999-10-19 | 2005-10-20 | The Procter & Gamble Company | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions |
| US20030077301A1 (en) * | 1999-12-16 | 2003-04-24 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| DE10361306A1 (de) * | 2003-12-24 | 2005-07-28 | Lts Lohmann Therapie-Systeme Ag | Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür |
| GB2409162B (en) * | 2004-10-06 | 2005-12-14 | Bhk Holding Ltd | Materials,methods,and apparatus for treating a body cavity |
| GB2447012B (en) | 2007-02-21 | 2011-03-16 | Pharmacure Health Care Ab | Composition for combating epistaxis |
-
2007
- 2007-02-21 GB GB0703377A patent/GB2447012B/en not_active Expired - Fee Related
-
2008
- 2008-02-21 DK DK08709491.8T patent/DK2117502T3/en active
- 2008-02-21 KR KR1020097019543A patent/KR20090130001A/ko not_active Ceased
- 2008-02-21 PL PL08709491T patent/PL2117502T3/pl unknown
- 2008-02-21 CA CA2678706A patent/CA2678706C/en active Active
- 2008-02-21 BR BRPI0807732A patent/BRPI0807732B8/pt not_active IP Right Cessation
- 2008-02-21 WO PCT/GB2008/000608 patent/WO2008102150A2/en not_active Ceased
- 2008-02-21 HR HRP20161626TT patent/HRP20161626T1/hr unknown
- 2008-02-21 PT PT87094918T patent/PT2117502T/pt unknown
- 2008-02-21 RU RU2009134086/15A patent/RU2473327C2/ru not_active IP Right Cessation
- 2008-02-21 EP EP08709491.8A patent/EP2117502B1/en active Active
- 2008-02-21 CN CN200880005428.8A patent/CN101677940B/zh not_active Expired - Fee Related
- 2008-02-21 ZA ZA200905519A patent/ZA200905519B/xx unknown
- 2008-02-21 ES ES08709491.8T patent/ES2606947T3/es active Active
- 2008-02-21 US US12/525,975 patent/US9138406B2/en active Active
- 2008-02-21 HU HUE08709491A patent/HUE031199T2/en unknown
- 2008-02-21 AU AU2008217608A patent/AU2008217608B2/en not_active Ceased
- 2008-02-21 JP JP2009550758A patent/JP2010519285A/ja active Pending
-
2009
- 2009-08-06 IL IL200277A patent/IL200277A0/en unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2156612C1 (ru) * | 2000-03-13 | 2000-09-27 | Волков Александр Григорьевич | Способ остановки носового кровотечения |
| US20030060486A1 (en) * | 2001-02-15 | 2003-03-27 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| WO2003000155A2 (en) * | 2001-06-22 | 2003-01-03 | Millard Marsden Mershon | Compositions and methods for reducing blood and fluid loss from open wounds |
| WO2006005340A1 (en) * | 2004-07-09 | 2006-01-19 | Ferrosan A/S | Haemostatic composition comprising hyaluronic acid |
| RU2290937C1 (ru) * | 2005-10-03 | 2007-01-10 | Владислав Владимирович Петров | Способ остановки носового кровотечения |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2678706A1 (en) | 2008-08-28 |
| HUE031199T2 (en) | 2017-07-28 |
| CA2678706C (en) | 2014-11-18 |
| GB0703377D0 (en) | 2007-03-28 |
| IL200277A0 (en) | 2010-04-29 |
| KR20090130001A (ko) | 2009-12-17 |
| CN101677940A (zh) | 2010-03-24 |
| BRPI0807732B8 (pt) | 2021-05-25 |
| HRP20161626T1 (hr) | 2017-03-10 |
| ZA200905519B (en) | 2010-10-27 |
| GB2447012B (en) | 2011-03-16 |
| US9138406B2 (en) | 2015-09-22 |
| PL2117502T3 (pl) | 2017-08-31 |
| RU2009134086A (ru) | 2011-03-27 |
| US20100119472A1 (en) | 2010-05-13 |
| JP2010519285A (ja) | 2010-06-03 |
| AU2008217608A1 (en) | 2008-08-28 |
| BRPI0807732A2 (pt) | 2014-06-03 |
| EP2117502B1 (en) | 2016-11-09 |
| PT2117502T (pt) | 2016-12-13 |
| AU2008217608B2 (en) | 2013-01-10 |
| CN101677940B (zh) | 2014-02-19 |
| BRPI0807732B1 (pt) | 2020-08-04 |
| GB2447012A (en) | 2008-09-03 |
| WO2008102150A3 (en) | 2009-04-30 |
| ES2606947T3 (es) | 2017-03-28 |
| WO2008102150A2 (en) | 2008-08-28 |
| DK2117502T3 (en) | 2017-01-23 |
| EP2117502A2 (en) | 2009-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5118633B2 (ja) | 医療用デバイスおよび医薬製剤において有用な粘膜付着性キシログルカン含有製剤 | |
| DK2222327T3 (en) | TOPICAL USE AND FORMULATION OF ERYTHROPOIETIN FOR HEALTH CARE | |
| CA2312558C (en) | Collagen containing tissue adhesive | |
| JPH0789871A (ja) | コラゲナーゼの高用量局所形剤 | |
| EP2520279A1 (en) | Thermoreversible gel pharamaceutical compositions for odontoiatric use | |
| KR20200020618A (ko) | 응집성이 개선된 창상피복재 조성물의 제조 방법 | |
| BRPI0620403B1 (pt) | filme bioadesivo, unidade de dosagem, método de fabricação de um filme bioadesivo, e, uso de uma composição | |
| US9433644B2 (en) | Formulations and methods for treating oral inflammation, injury, or pain | |
| CA2678706C (en) | Composition for combating epistaxis | |
| JP6595717B2 (ja) | 骨関節炎治療のための親水化されたスルファサラジンおよびヒアルロン酸を含む組成物およびその製造方法 | |
| JP2007522077A (ja) | 粘膜の疾患および障害の予防および処置のための液体製剤 | |
| TWI909127B (zh) | 含有麩醯胺酸的藥物組成物、製劑及其用途 | |
| US20230158051A1 (en) | Pharmaceutical paste formulations for site specific application | |
| CN116725949A (zh) | 盐酸布比卡因及多聚脱氧核糖核苷酸缓释凝胶注射液及其制备方法 | |
| RS60860B1 (sr) | Makrogoli za primenu na sluznicu i njihova terapijska upotreba | |
| RU2293557C2 (ru) | Средство для местного использования при лечении заболевания кожи и слизистых | |
| Khokhlenkova | Prospects of using biopolymeric films in medicine and pharmacy | |
| WO2025010400A2 (en) | Compositions and methods for improved treatment of skin wounds | |
| CN101138541B (zh) | 氨来占诺局部成膜凝胶组合物及其应用 | |
| KR102376345B1 (ko) | 상처 치료용 괴사조직제거 조성물 | |
| RU2455008C1 (ru) | Пролонгированная жидкая лекарственная форма на основе бишофита | |
| CN113679848A (zh) | 一种牙科基质辅料及其制备方法 | |
| JP2025181818A (ja) | 局所適用ハイドロゲル | |
| JP2014091740A (ja) | グリセリン浣腸剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20180222 |